Literature DB >> 27743381

Snail-activated long non-coding RNA PCA3 up-regulates PRKD3 expression by miR-1261 sponging, thereby promotes invasion and migration of prostate cancer cells.

Jin-Hua He1, Bao-Xia Li2, Ze-Ping Han1, Mao-Xian Zou1, Li Wang1, Yu-Bing Lv1, Jia-Bin Zhou1, Ming-Rong Cao3, Yu-Guang Li4, Jing-Zhi Zhang5.   

Abstract

Rapidly accumulated evidence has shown that long non-coding RNA (lncRNAs) disregulation is involved in human tumorigenesis in many cancers, including prostate cancer (PCa). LncRNAs can regulate essential pathways that contribute to tumor initiation and progression with tissue specificity, which suggests that lncRNAs could be valuable biomarkers and therapeutic targets. Prostate cancer antigen 3 (PCA3), also known as differential display code 3 (DD3), is one such lncRNA that maps to chromosome 9q21-22. PCA3 expression is highly specific to PCa. In the present study, the level of PCA3 expression in prostate cancer cells was reduced by small interfering RNA (siRNA). Subsequently, the ability of LNCaP cell proliferation, invasion, and migration of PCa was compromised both in vivo and in vitro with the occurrence of cell autophagy. Recently, a novel regulatory mechanism has been proposed in which RNAs cross talk via competing with the shared microRNAs (miRNAs). In addition, lncRNAs can directly interact with RNA-binding proteins and then bind to the gene promoter region to further regulate gene expression. The proposed competitive endogenous RNAs mediate the bioavailability of miRNAs on their targets, thus imposing another level of post-transcriptional regulation. Here, we demonstrated that binding of Snail to the promoter region of PCA3 could activate the expression of PCA3. Down-regulation of PCA3 by silencing could increase the expression of the miRNA-1261, which then targeted at the PRKD3 gene (protein kinase D3) through competitive sponging. In summary, these results suggest that the transcription factor, Snail, activated the expression of lncRNA PCA3, which could inhibit the translation of PRKD3 protein via competitive miR-1261 sponging, and thus high expression of PRKD3 further promoted invasion and migration of prostate cancer.

Entities:  

Keywords:  Differential display code 3; Long non-coding RNA; Prostate cancer cells; Protein kinase D3; Small interfering RNA sequences; microRNA-1261

Year:  2016        PMID: 27743381     DOI: 10.1007/s13277-016-5450-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  44 in total

Review 1.  Long non-coding RNAs: a new frontier in the study of human diseases.

Authors:  Xuefei Shi; Ming Sun; Hongbing Liu; Yanwen Yao; Yong Song
Journal:  Cancer Lett       Date:  2013-06-18       Impact factor: 8.679

2.  The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.

Authors:  Zilian Cui; Shancheng Ren; Ji Lu; Fubo Wang; Weidong Xu; Yi Sun; Min Wei; Junyi Chen; Xu Gao; Chuanliang Xu; Jian-Hua Mao; Yinghao Sun
Journal:  Urol Oncol       Date:  2012-01-20       Impact factor: 3.498

3.  The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.

Authors:  Kun Wang; Fang Liu; Lu-Yu Zhou; Bo Long; Shu-Min Yuan; Yin Wang; Cui-Yun Liu; Teng Sun; Xiao-Jie Zhang; Pei-Feng Li
Journal:  Circ Res       Date:  2014-02-20       Impact factor: 17.367

Review 4.  RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts.

Authors:  Sarah Geisler; Jeff Coller
Journal:  Nat Rev Mol Cell Biol       Date:  2013-10-09       Impact factor: 94.444

5.  p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy.

Authors:  Serhiy Pankiv; Terje Høyvarde Clausen; Trond Lamark; Andreas Brech; Jack-Ansgar Bruun; Heidi Outzen; Aud Øvervatn; Geir Bjørkøy; Terje Johansen
Journal:  J Biol Chem       Date:  2007-06-19       Impact factor: 5.157

6.  C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion.

Authors:  Xiaolu He; Xueming Tan; Xiang Wang; Heiying Jin; Li Liu; Limei Ma; Hong Yu; Zhining Fan
Journal:  Tumour Biol       Date:  2014-09-04

Review 7.  The hallmarks of cancer: a long non-coding RNA point of view.

Authors:  Tony Gutschner; Sven Diederichs
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

8.  The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients.

Authors:  M Avgeris; K Stravodimos; E G Fragoulis; A Scorilas
Journal:  Br J Cancer       Date:  2013-05-23       Impact factor: 7.640

9.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data.

Authors:  Jun-Hao Li; Shun Liu; Hui Zhou; Liang-Hu Qu; Jian-Hua Yang
Journal:  Nucleic Acids Res       Date:  2013-12-01       Impact factor: 16.971

10.  Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells.

Authors:  Jin-Hua He; Jing-Zhi Zhang; Ze-Ping Han; Li Wang; Yu Bing Lv; Yu-Guang Li
Journal:  J Exp Clin Cancer Res       Date:  2014-09-10
View more
  18 in total

1.  MiR-1261/circ-PTPRZ1/PAK1 pathway regulates glioma cell growth and invasion.

Authors:  Feng Zhang; Shu-Rong Mai; Fei-Peng Cao; Can-Xian Cao; Liang Zhang
Journal:  Hum Cell       Date:  2019-07-30       Impact factor: 4.174

2.  Ferroptosis is involved in the progression of hepatocellular carcinoma through the circ0097009/miR-1261/SLC7A11 axis.

Authors:  Ning Lyu; Yan Zeng; Yanan Kong; Qifeng Chen; Haijing Deng; Shunling Ou; Yanfang Bai; Hailin Tang; Xiaolan Wang; Ming Zhao
Journal:  Ann Transl Med       Date:  2021-04

3.  Clinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification.

Authors:  Yu Zhang; Wen-Jie Chen; Ting-Qing Gan; Xiu-Ling Zhang; Zu-Cheng Xie; Zhi-Hua Ye; Yun Deng; Ze-Feng Wang; Kai-Teng Cai; Shi-Kang Li; Dian-Zhong Luo; Gang Chen
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

Review 4.  The prognostic value of long noncoding RNAs in prostate cancer: a systematic review and meta-analysis.

Authors:  Weijie Ma; Xi Chen; Lu Ding; Jianhong Ma; Wei Jing; Tian Lan; Haseeb Sattar; Yongchang Wei; Fuling Zhou; Yufeng Yuan
Journal:  Oncotarget       Date:  2017-05-07

Review 5.  Carcinogenesis in prostate cancer: The role of long non-coding RNAs.

Authors:  John Aird; Anne-Marie Baird; Marvin C J Lim; Ray McDermott; Stephen P Finn; Steven G Gray
Journal:  Noncoding RNA Res       Date:  2018-02-01

Review 6.  Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications.

Authors:  Jens Staal; Rudi Beyaert
Journal:  Cells       Date:  2018-08-29       Impact factor: 6.600

Review 7.  The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression.

Authors:  U-Ging Lo; Cheng-Fan Lee; Ming-Shyue Lee; Jer-Tsong Hsieh
Journal:  Int J Mol Sci       Date:  2017-09-30       Impact factor: 5.923

Review 8.  Long non-coding RNAs involved in autophagy regulation.

Authors:  Lixian Yang; Hanying Wang; Qi Shen; Lifeng Feng; Hongchuan Jin
Journal:  Cell Death Dis       Date:  2017-10-05       Impact factor: 8.469

Review 9.  RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer-From Cell Line Models to Liquid Biopsies.

Authors:  Marvin C J Lim; Anne-Marie Baird; John Aird; John Greene; Dhruv Kapoor; Steven G Gray; Ray McDermott; Stephen P Finn
Journal:  Diagnostics (Basel)       Date:  2018-08-30

Review 10.  Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.

Authors:  Tao Xu; Chang-Ming Lin; Shu-Qi Cheng; Jie Min; Li Li; Xiao-Ming Meng; Cheng Huang; Lei Zhang; Zi-Yu Deng; Jun Li
Journal:  Mol Cancer       Date:  2018-07-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.